South African health authorities will soon know the effectiveness of a second dose of the Johnson & Johnson Covid-19 vaccine against the Omicron variant.
This, according to professor Glenda Gray, from the South African Medical Research Council.
Gray says healthcare workers who received one dose of the J&J injection, and who picked up breakthrough infections, developed only mild forms of the disease.
Audio PlayerGray says about 218,000 healthcare workers have already gotten a second dose of the J&J injection.
Audio PlayerRead the full report here.
Related articles:
- British Government moves forward roll-out of booster doses of Covid-19 vaccines by one month.
- Calls to reduce the price of Covid-19 PCR tests even further.
- Support for the TRIPS Covid-19 waiver starting to gain momentum.
COVID-19 vaccines
are our best shot to stay safe these holidays. Get your vaccine at a vaccination site near you and be protected https://t.co/6NUSwZuERI pic.twitter.com/39Uh6Vl6xZ
— @Discovery_SA (@Discovery_SA) December 15, 2021
